Recruiting Alpha-1 Antitrypsin Deficiency Studies in Tucson
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get ...
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some people, the liver makes an abnormal version of the AAT protein, called Z-AAT. Maki...
About Alpha-1 Antitrypsin Deficiency Clinical Trials in Tucson
Alpha-1 antitrypsin deficiency is a genetic condition that increases the risk of lung and liver disease due to low levels of the protective protein alpha-1 antitrypsin. It is one of the most common genetic causes of COPD. Treatment includes augmentation therapy and management of lung and liver symptoms.
There are currently 2 alpha-1 antitrypsin deficiency clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 210 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alpha-1 Antitrypsin Deficiency Clinical Trials in Tucson — FAQ
Are there alpha-1 antitrypsin deficiency clinical trials in Tucson?
Yes, there are 2 alpha-1 antitrypsin deficiency clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tucson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.
Are clinical trials in Tucson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.
What alpha-1 antitrypsin deficiency treatments are being tested?
The 2 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for alpha-1 antitrypsin deficiency.
Data updated March 2, 2026 from ClinicalTrials.gov